Financials
Income statement
| Fiscal date | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|
| Total reported revenue | 4.0B | 3.8B | 3.7B | 3.7B |
| Cost of revenue | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 320M | 383M | 307M | 322M |
| Other operating expenses | -7M | 142M | 0 | 0 |
| Operating income | — | — | — | — |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | — | — | — | — |
| Other income expense | — | — | — | — |
| Pretax income | 1.8B | 1.5B | 1.7B | 1.7B |
| Tax provision | 471M | 233M | 431M | 462M |
| Net income | 1.3B | 1.3B | 1.2B | 1.3B |
| Basic EPS | — | 0.3 | 0.3 | — |
| Diluted EPS | — | 0.3 | 0.3 | — |
| Basic average shares | — | 3.1B | 3.2B | — |
| Diluted average shares | — | 3.1B | 3.2B | — |
| EBITDA | — | — | — | — |
| Net income from continuing op. | — | — | — | — |
| Minority interests | 1M | 1M | 1M | -2M |
| Preferred stock dividends | 90M | 81M | 73M | 69M |